ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Preventive medications for treatment of migraine[1]

Preventive medications for treatment of migraine[1]
Class FDA approved for indication Class of evidence
Beta blockers: Propranolol, timolol Yes A
Calcium channel blockers: Verapamil No B
Antidepressants: Amitriptyline, nortriptyline, venlafaxine No B
Antiseizure medications: Sodium valproate, topiramate Yes A
NSAIDs: Naproxen No B
Onabotulinum toxin Yes A
CGRP monoclonal antibodies: Fremenazumab, galcanazemab, erenumab Yes A
FDA: US Food and Drug Administration; A: high-quality evidence from more than 1 RCT, meta-analyses of high-quality RCTs, 1 or more RCTs corroborated by high-quality registry studies; B: moderate-quality evidence from 1 or more RCTs, meta-analyses of moderate-quality RCTs; NSAIDs: nonsteroidal anti-inflammatory drugs; CGRP: calcitonin gene-related peptide; RCT: randomized controlled trials.
Reference:
  1. Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache 2012; 52:930.
From: Bernstein C, O'Neal M. Migraine and menopause - a narrative review. Menopause 2020. DOI: 10.1097/GME.0000000000001635. Copyright © 2020 The North American Menopause Society. Reproduced with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.
Graphic 128449 Version 3.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟